Table 1.
Baseline Characteristics of the Study Participants
| Total (N = 164 196) | Matched Controls (n = 82 098) | TB Survivors (n = 82 098) | |
|---|---|---|---|
| Age, y | 56.1 ± 15.4 | 56.1 ± 15.4 | 56.1 ± 15.4 |
| ȃ20–29 | 8656 (5.3) | 4328 (5.3) | 4328 (5.3) |
| ȃ30–39 | 18 178 (11.1) | 9089 (11.1) | 9089 (11.1) |
| ȃ40–49 | 29 274 (17.8) | 14 637 (17.8) | 14 637 (17.8) |
| ȃ50–59 | 36 260 (22.1) | 18 130 (22.1) | 18 130 (22.1) |
| ȃ60–69 | 32 428 (19.8) | 16 214 (19.8) | 16 214 (19.8) |
| ȃ70–79 | 32 192 (19.6) | 16 096 (19.6) | 16 096 (19.6) |
| ȃ≥ 80 | 7208 (4.4) | 3604 (4.4) | 3604 (4.4) |
| Sex | |||
| ȃMale | 93 510 (56.9) | 46 755 (56.9) | 46 755 (56.9) |
| ȃFemale | 70 686 (43.1) | 35 343 (43.1) | 35 343 (43.1) |
| BMI, kg/m2 | 23.0 ± 3.3 | 23.9 ± 3.2 | 22.2 ± 3.1 |
| ȃ<18.5 | 11 063 (6.7) | 2820 (3.4) | 8243 (10.0) |
| ȃ18–22.9 | 73 115 (44.5) | 30 091 (36.7) | 43 024 (52.4) |
| ȃ23–24.9 | 37 205 (22.7) | 20 825 (25.4) | 16 380 (20.0) |
| ȃ≥25 | 42 813 (26.1) | 28 362 (34.5) | 14 451 (17.6) |
| Smoking status | |||
| ȃNever smoker | 96 576 (58.8) | 49 570 (60.4) | 47 006 (57.3) |
| ȃEx-smoker | 28 701 (17.5) | 15 417 (18.8) | 13 284 (16.2) |
| ȃCurrent smoker | 38 919 (23.7) | 17 111 (20.8) | 21 808 (26.5) |
| Smoking pack-years | 8.0 ± 14.3 | 7.2 ± 13.1 | 8.9 ± 15.3 |
| Alcohol consumption | |||
| ȃNone | 92 907 (56.6) | 45 969 (55.9) | 46 938 (57.2) |
| ȃMild | 58 157 (35.4) | 30 667 (37.4) | 27 490 (33.5) |
| ȃHeavy | 13 132 (8.0) | 5462 (6.7) | 7670 (9.3) |
| Regular exercise | |||
| ȃNo | 133 129 (81.1) | 65 115 (79.3) | 68 014 (82.8) |
| ȃYes | 31 067 (18.9) | 16 983 (20.7) | 14 084 (17.2) |
| Income | |||
| ȃQuintile 1 (lowest) | 29 485 (18.0) | 14 253 (17.4) | 15 232 (18.6) |
| ȃQuintile 2 | 24 242 (14.8) | 11 313 (13.8) | 12 929 (15.8) |
| ȃQuintile 3 | 28 951 (17.6) | 13 733 (16.7) | 15 218 (18.5) |
| ȃQuintile 4 | 35 808 (21.8) | 17 867 (21.8) | 17 941 (21.9) |
| ȃQuintile 5 | 45 710 (27.8) | 24 932 (30.3) | 20 778 (25.2) |
| Residential area | |||
| ȃMetropolitan | 71 648 (43.6) | 35 204 (42.9) | 36 444 (44.4) |
| ȃOther area | 92 548 (56.4) | 46 894 (57.1) | 45 654 (55.6) |
| Comorbidities | |||
| ȃDiabetes mellitus | 30 568 (18.6) | 12 841 (15.6) | 17 727 (21.6) |
| ȃHypertension | 52 432 (31.9) | 26 875 (32.7) | 25 557 (31.1) |
| ȃDyslipidemia | 48 138 (29.3) | 22 590 (27.5) | 25 548 (31.1) |
| Respiratory disease | |||
| ȃAsthma | 28 236 (17.2) | 8563 (10.4) | 19 673 (24.0) |
| ȃCOPD | 25 468 (15.5) | 6077 (7.4) | 19 391 (23.6) |
| ȃBronchiectasis | 5133 (3.1) | 456 (0.6) | 4677 (5.7) |
| Cardiovascular disease | |||
| ȃIschemic heart disease | 13 154 (8.0) | 5945 (7.2) | 7209 (8.8) |
| ȃMyocardial infarction | 1054 (0.6) | 413 (0.5) | 641 (0.8) |
| ȃCongestive heart failure | 3994 (2.4) | 1421 (1.7) | 2573 (3.1) |
| ȃStroke | 1260 (0.8) | 456 (0.6) | 804 (1.0) |
| ȃCKD or ESRD | 11 878 (7.2) | 5678 (6.9) | 6200 (7.6) |
| Malignancy | |||
| ȃSold cancer | 6962 (4.2) | 2437 (3.0) | 4525 (5.5) |
| ȃHematologic malignancy | 237 (0.1) | 56 (0.1) | 181 (0.2) |
| Dementia | 2111 (1.3) | 996 (1.2) | 1115 (1.4) |
| Charlson Comorbidity Index | 1.8 ± 1.9 | 1.3 ± 1.6 | 2.3 ± 2.0 |
| ȃ0 | 51 384 (31.3) | 34 964 (42.6) | 16 420 (20.0) |
| ȃ1 | 37 292 (22.7) | 18 797 (22.9) | 18 495 (22.5) |
| ȃ2 | 28 048 (17.1) | 12 292 (15.0) | 15 756 (19.2) |
| ȃ≥3 | 47 472 (28.9) | 16 045 (19.5) | 31 427 (38.3) |
Data are presented as number (%) and mean ± standard deviation.
Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; ESRD, end-stage renal disease; TB, tuberculosis.